$SPPI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SPECTRUM PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SPECTRUM PHARMACEUTICALS INC. Get notifications about new insider transactions in SPECTRUM PHARMACEUTICALS INC for free.
Page: < prev 1 2 3 4 5 6 7 ... 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 13 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 19.93 | 30,000 | 597,900 | 1,239,977 | 1.3 M to 1.2 M (-2.36 %) |
Apr 13 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 20.72 | 30,000 | 621,600 | 1,269,977 | 1.3 M to 1.3 M (-2.31 %) |
Apr 13 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 20.30 | 30,000 | 609,000 | 1,299,977 | 1.3 M to 1.3 M (-2.26 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 17.74 | 30,000 | 532,200 | 1,329,977 | 1.4 M to 1.3 M (-2.21 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 17.74 | 30,000 | 532,200 | 1,329,977 | 1.4 M to 1.3 M (-2.21 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.01 | 12,300 | 184,623 | 1,359,977 | 1.4 M to 1.4 M (-0.90 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.01 | 12,300 | 184,623 | 1,359,977 | 1.4 M to 1.4 M (-0.90 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.00 | 3,686 | 55,290 | 1,372,277 | 1.4 M to 1.4 M (-0.27 %) |
Apr 10 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.00 | 3,686 | 55,290 | 1,372,277 | 1.4 M to 1.4 M (-0.27 %) |
Apr 05 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.33 | 30,000 | 459,900 | 1,375,963 | 1.4 M to 1.4 M (-2.13 %) |
Apr 05 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.01 | 30,000 | 450,300 | 1,405,963 | 1.4 M to 1.4 M (-2.09 %) |
Apr 05 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.14 | 30,000 | 454,200 | 1,435,963 | 1.5 M to 1.4 M (-2.05 %) |
Apr 02 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 15.61 | 30,000 | 468,300 | 1,465,963 | 1.5 M to 1.5 M (-2.01 %) |
Apr 02 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 16.18 | 30,000 | 485,400 | 1,495,963 | 1.5 M to 1.5 M (-1.97 %) |
Apr 02 2018 | SPPI | SPECTRUM PHARMACEU ... | Riga Thomas J | Chief Operating Off ... | Sell | S | 15.58 | 1,948 | 30,350 | 256,452 | 258.4 K to 256.5 K (-0.75 %) |
Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | CEO & President | Sell | S | 16.40 | 4,810 | 78,884 | 328,074 | 332.9 K to 328.1 K (-1.44 %) |
Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 16.35 | 4,350 | 71,123 | 187,193 | 191.5 K to 187.2 K (-2.27 %) |
Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 16.19 | 30,000 | 485,700 | 1,525,963 | 1.6 M to 1.5 M (-1.93 %) |
Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 17.10 | 30,000 | 513,000 | 1,555,963 | 1.6 M to 1.6 M (-1.89 %) |
Mar 28 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Sell | S | 17.34 | 30,000 | 520,200 | 1,585,963 | 1.6 M to 1.6 M (-1.86 %) |
Mar 27 2018 | SPPI | SPECTRUM PHARMACEU ... | Riga Thomas J | Chief Operating Off ... | Sell | S | 17.41 | 220 | 3,830 | 251,476 | 251.7 K to 251.5 K (-0.09 %) |
Mar 27 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 17.38 | 1,300 | 22,594 | 191,543 | 192.8 K to 191.5 K (-0.67 %) |
Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | M | 2.55 | 30,000 | 76,500 | 0 | |
Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Sell | S | 18.64 | 4,200 | 78,278 | 79,057 | 83.3 K to 79.1 K (-5.04 %) |
Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Buy | M | 2.55 | 30,000 | 76,500 | 83,257 | 53.3 K to 83.3 K (+56.33 %) |
Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | CEO & President | Sell | S | 18.17 | 3,100 | 56,327 | 332,884 | 336 K to 332.9 K (-0.92 %) |
Mar 23 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Sell | S | 18.13 | 2,640 | 47,868 | 192,843 | 195.5 K to 192.8 K (-1.35 %) |
Mar 12 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 2.55 | 500,000 | 1,275,000 | 0 | |
Mar 12 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 2.55 | 500,000 | 1,275,000 | 1,787,542 | 1.3 M to 1.8 M (+38.83 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Gift | G | 0.00 | 1,431 | 0 | 67,144 | 68.6 K to 67.1 K (-2.09 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Gift | G | 0.00 | 774 | 0 | 68,575 | 69.3 K to 68.6 K (-1.12 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Gift | G | 0.00 | 20,000 | 0 | 200,652 | 220.7 K to 200.7 K (-9.06 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Grant | A | 0.00 | 200,652 | 0 | 200,652 | 0 to 200.7 K |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Riga Thomas J | Chief Operating Off ... | Option Exercise | A | 19.42 | 175,000 | 3,398,500 | 175,000 | |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Riga Thomas J | Chief Operating Off ... | Grant | A | 0.00 | 100,000 | 0 | 251,696 | 151.7 K to 251.7 K (+65.92 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | CEO & President | Option Exercise | A | 19.42 | 175,000 | 3,398,500 | 175,000 | |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | CEO & President | Grant | A | 0.00 | 38,889 | 0 | 335,984 | 297.1 K to 336 K (+13.09 %) |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 19.42 | 87,500 | 1,699,250 | 87,500 | |
Jan 19 2018 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 19,445 | 0 | 195,483 | 176 K to 195.5 K (+11.05 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 6.69 | 58,480 | 391,231 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 5.86 | 412,500 | 2,417,250 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 7.24 | 622,376 | 4,506,002 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 9.18 | 650,000 | 5,967,000 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 11.34 | 955,847 | 10,839,305 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 8.27 | 500,000 | 4,135,000 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 6.87 | 985,444 | 6,770,000 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 3.92 | 500,000 | 1,960,000 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 4.65 | 478,495 | 2,225,002 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 7.24 | 27,624 | 199,998 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Option Exercise | M | 11.34 | 8,818 | 99,996 | 0 | |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Payment of Exercise | F | 18.03 | 3,500,294 | 63,110,301 | 3,488,337 | 7 M to 3.5 M (-50.09 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 6.69 | 58,480 | 391,231 | 6,988,631 | 6.9 M to 7 M (+0.84 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 5.86 | 412,500 | 2,417,250 | 6,930,151 | 6.5 M to 6.9 M (+6.33 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 7.24 | 622,376 | 4,506,002 | 6,517,651 | 5.9 M to 6.5 M (+10.56 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 9.18 | 650,000 | 5,967,000 | 5,895,275 | 5.2 M to 5.9 M (+12.39 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 11.34 | 955,847 | 10,839,305 | 5,245,275 | 4.3 M to 5.2 M (+22.28 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 8.27 | 500,000 | 4,135,000 | 4,289,428 | 3.8 M to 4.3 M (+13.19 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 6.87 | 985,444 | 6,770,000 | 3,789,428 | 2.8 M to 3.8 M (+35.14 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 3.92 | 500,000 | 1,960,000 | 2,803,984 | 2.3 M to 2.8 M (+21.70 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 4.65 | 478,495 | 2,225,002 | 2,303,984 | 1.8 M to 2.3 M (+26.21 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 7.24 | 27,624 | 199,998 | 1,825,489 | 1.8 M to 1.8 M (+1.54 %) |
Jan 11 2018 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Director | Buy | M | 11.34 | 8,818 | 99,996 | 1,797,865 | 1.8 M to 1.8 M (+0.49 %) |
Dec 22 2017 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 611,740 | 6,117 | 4,650,262 | 4 M to 4.7 M (+15.15 %) |
Dec 22 2017 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 907,356 | 9,074 | 6,897,413 | 6 M to 6.9 M (+15.15 %) |
Dec 04 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Option Exercise | M | 3.15 | 100,000 | 315,000 | 0 | |
Dec 04 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Gift | G | 19.04 | 27,666 | 526,761 | 1,829,047 | 1.9 M to 1.8 M (-1.49 %) |
Dec 04 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Payment of Exercise | F | 19.04 | 27,666 | 526,761 | 170,473 | 198.1 K to 170.5 K (-13.96 %) |
Dec 04 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Payment of Exercise | F | 19.04 | 16,545 | 315,017 | 198,139 | 214.7 K to 198.1 K (-7.71 %) |
Dec 04 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Buy | M | 3.15 | 100,000 | 315,000 | 214,684 | 114.7 K to 214.7 K (+87.20 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | M | 6.90 | 15,000 | 103,500 | 0 | |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 7.53 | 442 | 3,328 | 22,988 | 23.4 K to 23 K (-1.89 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 7.53 | 13,745 | 103,500 | 23,430 | 37.2 K to 23.4 K (-36.97 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Buy | M | 6.90 | 15,000 | 103,500 | 37,175 | 22.2 K to 37.2 K (+67.64 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | M | 6.90 | 15,000 | 103,500 | 0 | |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 7.53 | 442 | 3,328 | 53,257 | 53.7 K to 53.3 K (-0.82 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 7.53 | 13,745 | 103,500 | 53,699 | 67.4 K to 53.7 K (-20.38 %) |
Jul 18 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Buy | M | 6.90 | 15,000 | 103,500 | 67,444 | 52.4 K to 67.4 K (+28.60 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | Vyas Dolatrai | Director | Payment of Exercise | F | 7.54 | 792 | 5,972 | 37,079 | 37.9 K to 37.1 K (-2.09 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Payment of Exercise | F | 7.54 | 625 | 4,713 | 69,077 | 69.7 K to 69.1 K (-0.90 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 7.54 | 880 | 6,635 | 22,175 | 23.1 K to 22.2 K (-3.82 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 7.54 | 880 | 6,635 | 52,444 | 53.3 K to 52.4 K (-1.65 %) |
Jun 29 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 7.54 | 625 | 4,713 | 43,125 | 43.8 K to 43.1 K (-1.43 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Vyas Dolatrai | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Vyas Dolatrai | Director | Grant | A | 0.00 | 10,000 | 0 | 37,871 | 27.9 K to 37.9 K (+35.88 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Vyas Dolatrai | Director | Payment of Exercise | F | 6.48 | 3,170 | 20,542 | 27,871 | 31 K to 27.9 K (-10.21 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Grant | A | 0.00 | 10,000 | 0 | 69,702 | 59.7 K to 69.7 K (+16.75 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 59,702 | 62.2 K to 59.7 K (-4.02 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Grant | A | 0.00 | 10,000 | 0 | 23,055 | 13.1 K to 23.1 K (+76.60 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 6.48 | 3,523 | 22,829 | 13,055 | 16.6 K to 13.1 K (-21.25 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Grant | A | 0.00 | 10,000 | 0 | 53,324 | 43.3 K to 53.3 K (+23.08 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Grant | A | 0.00 | 10,000 | 0 | 53,324 | 43.3 K to 53.3 K (+23.08 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 6.48 | 3,523 | 22,829 | 43,324 | 46.8 K to 43.3 K (-7.52 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 6.48 | 3,523 | 22,829 | 43,324 | 46.8 K to 43.3 K (-7.52 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Grant | A | 0.00 | 10,000 | 0 | 82,500 | 72.5 K to 82.5 K (+13.79 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Grant | A | 0.00 | 10,000 | 0 | 82,500 | 72.5 K to 82.5 K (+13.79 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 72,500 | 75 K to 72.5 K (-3.33 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | Gagnon Gilles | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 72,500 | 75 K to 72.5 K (-3.33 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.48 | 20,000 | 129,600 | 20,000 | |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Grant | A | 0.00 | 10,000 | 0 | 43,750 | 33.8 K to 43.8 K (+29.63 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
Jun 15 2017 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Payment of Exercise | F | 6.48 | 2,500 | 16,200 | 33,750 | 36.3 K to 33.8 K (-6.90 %) |
Jun 05 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 5.96 | 9,395 | 55,994 | 171,393 | 180.8 K to 171.4 K (-5.20 %) |
Apr 19 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 6.32 | 8,205 | 51,856 | 297,095 | 305.3 K to 297.1 K (-2.69 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Option Exercise | A | 6.69 | 116,959 | 782,456 | 116,959 | |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.69 | 4,713 | 31,530 | 180,788 | 185.5 K to 180.8 K (-2.54 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Grant | A | 0.00 | 50,163 | 0 | 185,501 | 135.3 K to 185.5 K (+37.06 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Option Exercise | A | 6.69 | 155,556 | 1,040,670 | 155,556 | |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 6.69 | 4,562 | 30,520 | 305,300 | 309.9 K to 305.3 K (-1.47 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Grant | A | 0.00 | 66,717 | 0 | 309,862 | 243.1 K to 309.9 K (+27.44 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Option Exercise | A | 6.69 | 233,918 | 1,564,911 | 233,918 | |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Payment of Exercise | F | 6.69 | 6,860 | 45,893 | 1,876,713 | 1.9 M to 1.9 M (-0.36 %) |
Mar 30 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Grant | A | 0.00 | 100,326 | 0 | 1,883,573 | 1.8 M to 1.9 M (+5.63 %) |
Mar 28 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.61 | 1,410 | 9,320 | 135,338 | 136.7 K to 135.3 K (-1.03 %) |
Mar 24 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Payment of Exercise | F | 6.42 | 6,838 | 43,900 | 1,783,247 | 1.8 M to 1.8 M (-0.38 %) |
Mar 24 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 6.42 | 3,419 | 21,950 | 243,145 | 246.6 K to 243.1 K (-1.39 %) |
Mar 24 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 6.42 | 2,819 | 18,098 | 136,748 | 139.6 K to 136.7 K (-2.02 %) |
Feb 22 2017 | SPPI | SPECTRUM PHARMACEU ... | SHROTRIYA RAJESH C MD | Chairman & CEO | Payment of Exercise | F | 5.91 | 6,939 | 41,009 | 1,790,085 | 1.8 M to 1.8 M (-0.39 %) |
Feb 22 2017 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 5.91 | 4,026 | 23,794 | 246,564 | 250.6 K to 246.6 K (-1.61 %) |
Feb 22 2017 | SPPI | SPECTRUM PHARMACEU ... | GUSTAFSON KURT A | EVP & Chief Financi ... | Payment of Exercise | F | 5.91 | 2,471 | 14,604 | 139,567 | 142 K to 139.6 K (-1.74 %) |
Dec 06 2016 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 4.00 | 1,710 | 6,840 | 250,590 | 252.3 K to 250.6 K (-0.68 %) |
Nov 01 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 198,765 | 1,988 | 4,038,522 | 3.8 M to 4 M (+5.18 %) |
Nov 01 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 521,692 | 5,217 | 3,839,757 | 3.3 M to 3.8 M (+15.72 %) |
Nov 01 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 294,815 | 2,948 | 5,990,057 | 5.7 M to 6 M (+5.18 %) |
Nov 01 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 773,790 | 7,738 | 5,695,242 | 4.9 M to 5.7 M (+15.72 %) |
Nov 01 2016 | SPPI | SPECTRUM PHARMACEU ... | Turgeon Joseph W. | President & COO | Payment of Exercise | F | 3.67 | 1,710 | 6,276 | 252,300 | 254 K to 252.3 K (-0.67 %) |
Aug 16 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 66,255 | 663 | 3,318,065 | 3.3 M to 3.3 M (+2.04 %) |
Aug 16 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 394,942 | 3,949 | 3,251,810 | 2.9 M to 3.3 M (+13.82 %) |
Aug 16 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 98,271 | 983 | 4,921,452 | 4.8 M to 4.9 M (+2.04 %) |
Aug 16 2016 | SPPI | SPECTRUM PHARMACEU ... | SPECTRUM PHARMACEUTICALS INC | 10% Owner | Buy | P | 0.01 | 585,790 | 5,858 | 4,823,181 | 4.2 M to 4.8 M (+13.82 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 | |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Grant | A | 0.00 | 10,000 | 0 | 46,847 | 36.8 K to 46.8 K (+27.14 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 6.33 | 3,523 | 22,301 | 36,847 | 40.4 K to 36.8 K (-8.73 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | Krassner Stuart Mitchell | Director | Payment of Exercise | F | 6.47 | 880 | 5,694 | 40,370 | 41.3 K to 40.4 K (-2.13 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 | |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Grant | A | 0.00 | 10,000 | 0 | 62,202 | 52.2 K to 62.2 K (+19.16 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Payment of Exercise | F | 6.33 | 2,500 | 15,825 | 52,202 | 54.7 K to 52.2 K (-4.57 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | LENAZ LUIGI MD | Director | Payment of Exercise | F | 6.47 | 625 | 4,044 | 54,702 | 55.3 K to 54.7 K (-1.13 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 | |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Grant | A | 0.00 | 10,000 | 0 | 29,745 | 19.7 K to 29.7 K (+50.65 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 6.33 | 3,523 | 22,301 | 19,745 | 23.3 K to 19.7 K (-15.14 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | MAIDA ANTHONY E III | Director | Payment of Exercise | F | 6.47 | 880 | 5,694 | 23,268 | 24.1 K to 23.3 K (-3.64 %) |
Jun 29 2016 | SPPI | SPECTRUM PHARMACEU ... | COHEN RAYMOND W | Director | Option Exercise | A | 6.33 | 20,000 | 126,600 | 20,000 |